BrightSpring Health Services (BTSG) – Research Analysts’ Recent Ratings Changes

Several brokerages have updated their recommendations and price targets on shares of BrightSpring Health Services (NASDAQ: BTSG) in the last few weeks:

• 6/8/2026 – BrightSpring Health Services is now covered by The Goldman Sachs Group, Inc.. They set a “buy” rating and a $71.00 price target on the stock.
• 6/2/2026 – BrightSpring Health Services had its price target raised by Morgan Stanley from $62.00 to $71.00. They now have an “overweight” rating on the stock.
• 5/23/2026 – BrightSpring Health Services was downgraded by Wall Street Zen from “strong-buy” to “buy”.
• 5/21/2026 – BrightSpring Health Services was given a new $70.00 price target by BMO Capital Markets.
• 5/9/2026 – BrightSpring Health Services was upgraded by Wall Street Zen from “buy” to “strong-buy”.
• 5/6/2026 – BrightSpring Health Services had its price target raised by Morgan Stanley from $48.00 to $62.00. They now have an “overweight” rating on the stock.
• 5/5/2026 – BrightSpring Health Services had its price target raised by Mizuho from $52.00 to $61.00. They now have an “outperform” rating on the stock.
• 5/4/2026 – BrightSpring Health Services was upgraded by Weiss Ratings from “hold (c)” to “buy (b-)”.
• 5/4/2026 – BrightSpring Health Services had its “buy” rating reaffirmed by Deutsche Bank Aktiengesellschaft. They now have a $60.00 price target on the stock.
• 5/4/2026 – BrightSpring Health Services had its price target raised by TD Cowen from $60.00 to $65.00. They now have a “buy” rating on the stock.
• 5/4/2026 – BrightSpring Health Services had its price target raised by Stephens from $53.00 to $64.00. They now have an “overweight” rating on the stock.
• 5/4/2026 – BrightSpring Health Services had its price target raised by KeyCorp from $55.00 to $60.00. They now have an “overweight” rating on the stock.
• 5/4/2026 – BrightSpring Health Services had its price target raised by Wells Fargo & Company from $50.00 to $61.00. They now have an “overweight” rating on the stock.
• 5/4/2026 – BrightSpring Health Services had its price target raised by BTIG Research from $55.00 to $65.00. They now have a “buy” rating on the stock.
• 5/1/2026 – BrightSpring Health Services had its price target raised by BMO Capital Markets from $52.00 to $60.00. They now have an “outperform” rating on the stock.

Insider Activity at BrightSpring Health Services

In other news, insider Lisa A. Nalley sold 35,000 shares of the stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $58.75, for a total value of $2,056,250.00. Following the completion of the sale, the insider directly owned 131,948 shares in the company, valued at $7,751,945. This represents a 20.96% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Jon B. Rousseau sold 130,000 shares of the stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $58.75, for a total transaction of $7,637,500.00. Following the completion of the sale, the insider owned 1,194,503 shares of the company’s stock, valued at $70,177,051.25. This trade represents a 9.82% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 2.80% of the stock is currently owned by insiders.

BrightSpring Health Services (NASDAQ: BTSG) is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company’s operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.

Through its network of subsidiary brands, BrightSpring offers integrated care in the patient’s home environment, fostering independence and improving quality of life.